Trademark: 97386962
Status Date
Friday, March 29, 2024
Filing Date
Thursday, April 28, 2022
Published for Opposition
Tuesday, March 21, 2023
5 Pharmaceutical preparations for the treatment of diabetes only, not for intravenous administration or administration by infusion; none of the foregoing for treatment, or any associated treatment, of blood disorders or immunological diseases
Mar 30, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 29, 2024
Allowed Principal Register - Sou Accepted
Feb 29, 2024
Statement Of Use Processing Complete
Feb 5, 2024
Use Amendment Filed
Feb 24, 2024
Case Assigned To Intent To Use Paralegal
Feb 5, 2024
Teas Statement Of Use Received
Jan 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2024
Sou Extension 1 Granted
Jan 3, 2024
Sou Extension 1 Filed
Jan 3, 2024
Sou Teas Extension Received
Jan 3, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 3, 2024
Teas Change Of Correspondence Received
Jan 3, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 3, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 22, 2023
Extension Of Time To Oppose Process - Terminated
Jun 13, 2023
Changes/Corrections After Pub Approval Entered
Jun 12, 2023
Assigned To Petition Staff
May 25, 2023
Teas Post Publication Amendment Received
Apr 19, 2023
Extension Of Time To Oppose Received
Mar 21, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 21, 2023
Published For Opposition
Mar 1, 2023
Notification Of Notice Of Publication E-Mailed
Feb 16, 2023
Approved For Pub - Principal Register
Feb 15, 2023
Assigned To Examiner
May 3, 2022
New Application Office Supplied Data Entered
May 2, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
